hsa-mir-885: Hsa-mir-885 is a microRNA that has been studied in various contexts. It has been found to exhibit an inverse association with hsa-miR-424 in modulating the expression of CALM genes [PMC6682788]. Hsa-mir-885, along with hsa-miR-424 and hsa-miR-29c, is involved in the regulation of genes belonging to the CALM family [PMC6682788]. In glioblastoma (GBM) and Alzheimer's disease (AD), hsa-mir-885 is differentially expressed, with upregulation in GBM and downregulation in AD [PMC6682788]. Hsa-mir-885 is also upregulated in the complement score-high group, indicating its potential role as a tumor suppressor miRNA [PMC9828444]. It has been identified as a prognostic miRNA along with other miRNAs such as hsa-mir-421, hsa-mir-495, hsa-mir-194-2, and hsa-mir-30d [PMC9598836]. Although its direct relationship with low-grade glioma (LGG) has not been investigated yet, existing studies suggest an association between hsa-mir-885 and LGG based on its expression in cancer cells [PMC9598836]. Hsa-mir-885 has also been found to be overexpressed in patients with primary osteoarthritis [PMC5728069]. In terms of cytokine and chemokine correlation analysis, there is a good correlation between hsa-miR326 and IL6, as well as between hsa-miR15b and IL6. HSA-MIR 885 also shows correlation to IL15. It also shows positive correlation to influenza B infection but negative correlation to influenza A infection. In breast cancer cells, hsa-mir-885 directly targets B7-H3, suggesting its role in modulating B7-H3 protein expression [PMC6749327].